BioSpace News Archive

Lone Star Bio

Aerin Medical Achieves Significant Milestone with over 1,000 Patients Treated with VIVAER

Aerin Medical, Inc. announced that over 1,000 patients suffering from nasal obstruction have successfully received the VIVAER® Nasal Airway Remodeling treatment

July 31, 2018
·
2 min read
Pharm Country

Early Adopters Say Atellica Solution Exceeds Their Performance Expectations and Delivers Unprecedented Efficiencies

As the shortage of skilled clinical laboratory workers continues to rise, the Atellica Solution by Siemens Healthineers is proving to be a valuable asset for laboratories.

July 31, 2018
·
9 min read
Business

Amgen Announces 2018 Third Quarter Dividend

Amgen announced that its Board of Directors declared a $1.32 per share dividend for the third quarter of 2018.

July 31, 2018
·
5 min read
Policy

Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)

The European Commission decision marks the approval of Pfizer’s first therapeutic oncology biosimilar

July 31, 2018
·
11 min read
Business

NovaBay Pharmaceuticals to Hold Second Quarter 2018 Conference Call on August 7, 2018

NovaBay® Pharmaceuticals, Inc. announces that it will report second quarter 2018 financial results after market close on Tuesday, August 7.

July 31, 2018
·
2 min read
Pharm Country

Eisai and Merck Announce FDA Grants Breakthrough Therapy Designation for LENVIMA® (lenvatinib) in Combination with KEYTRUDA® (pembrolizumab)

Eisai Co., Ltd. and Merck announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for LENVIMA® (lenvatinib)

July 31, 2018
·
41 min read
Pharm Country

Curcumin Extract Targets Fatty Liver Disease

Research suggests BCM-95® Curcumin could be effective in the prevention and treatment of Non-Alcoholic Fatty Liver Disease

July 31, 2018
·
3 min read
BioMidwest

Roche to showcase how labs are driving change across health networks to address PAMA and other challenges at AACC 2018 Clinical Lab Expo

Featured labs address challenges by streamlining processes, reducing costs and optimizing operations while ensuring delivery of care

July 31, 2018
·
6 min read
Biotech Bay

Glaucoma Research Foundation Grant Leads to Major Breakthrough in Neuron Regeneration

Study indicates treatment using insulin may restore vision in glaucoma patients.

July 31, 2018
·
4 min read
Pharm Country

European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for the Adjuvant Treatment of Adult Patients with Melanoma with Involvement of Lymph Nodes or Metastatic Disease Who Have Undergone Complete Resection

Opdivo is the first and only PD-1 agent with an approved adjuvant therapy indication in the European Union

July 31, 2018
·
32 min read